D. Nagarjuna

670 total citations
11 papers, 98 citations indexed

About

D. Nagarjuna is a scholar working on Molecular Medicine, Endocrinology and Pharmacology. According to data from OpenAlex, D. Nagarjuna has authored 11 papers receiving a total of 98 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Medicine, 6 papers in Endocrinology and 3 papers in Pharmacology. Recurrent topics in D. Nagarjuna's work include Antibiotic Resistance in Bacteria (6 papers), Escherichia coli research studies (5 papers) and Bacteriophages and microbial interactions (3 papers). D. Nagarjuna is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Escherichia coli research studies (5 papers) and Bacteriophages and microbial interactions (3 papers). D. Nagarjuna collaborates with scholars based in India, Tunisia and Denmark. D. Nagarjuna's co-authors include Manisha Yadav, Rajni Gaind, Rakesh Singh Dhanda, Mohit Arora, Anita Verma, Md Sabir Alam, Harvinder Singh Chhabra, Pradeep Debata, Harvinder Singh Chhabra and Shruti Jain and has published in prestigious journals such as CNS & Neurological Disorders - Drug Targets, Antimicrobial Resistance and Infection Control and Global Spine Journal.

In The Last Decade

D. Nagarjuna

10 papers receiving 94 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Nagarjuna India 7 36 32 18 17 17 11 98
Minmin Lin China 5 46 1.3× 16 0.5× 12 0.7× 8 0.5× 16 0.9× 10 158
Diana Mūnoz Sandoval Ecuador 4 30 0.8× 9 0.3× 23 1.3× 3 0.2× 17 1.0× 9 132
Liangyi Xie China 7 34 0.9× 13 0.4× 15 0.8× 12 0.7× 7 0.4× 12 79
Gábor Ternák Hungary 8 30 0.8× 14 0.4× 76 4.2× 14 0.8× 5 0.3× 27 188
Vicente Merino‐Bohórquez Spain 6 26 0.7× 6 0.2× 25 1.4× 33 1.9× 3 0.2× 21 135
Maitane Aranzamendi Spain 7 63 1.8× 28 0.9× 25 1.4× 21 1.2× 2 0.1× 12 130
Laura Paone Italy 5 57 1.6× 27 0.8× 28 1.6× 14 0.8× 2 0.1× 6 104
Yujiro Uchida Japan 6 54 1.5× 24 0.8× 21 1.2× 19 1.1× 14 117
I. Bátai Hungary 6 17 0.5× 37 1.2× 22 1.2× 16 0.9× 2 0.1× 11 111

Countries citing papers authored by D. Nagarjuna

Since Specialization
Citations

This map shows the geographic impact of D. Nagarjuna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Nagarjuna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Nagarjuna more than expected).

Fields of papers citing papers by D. Nagarjuna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Nagarjuna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Nagarjuna. The network helps show where D. Nagarjuna may publish in the future.

Co-authorship network of co-authors of D. Nagarjuna

This figure shows the co-authorship network connecting the top 25 collaborators of D. Nagarjuna. A scholar is included among the top collaborators of D. Nagarjuna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Nagarjuna. D. Nagarjuna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Verma, Anita, et al.. (2022). Rationalizing the Use of Polyphenol Nano-formulations in the Therapy ofNeurodegenerative Diseases. CNS & Neurological Disorders - Drug Targets. 21(10). 966–976. 10 indexed citations
3.
Nagarjuna, D., Rym Ben Sallem, Vivek Verma, et al.. (2021). IDENTIFICATION OF VIRULENCE FACTORS AMONG ESBL-PRODUCING ESCHERICHIA COLI CLINICAL ISOLATES FROM GAZA STRIP, PALESTINE. Journal of Microbiology Biotechnology and Food Sciences. 11(3). e2865–e2865. 3 indexed citations
4.
Nagarjuna, D., Rym Ben Sallem, Vivek Verma, et al.. (2020). First report of VIM metallo-β-lactamase production in Escherichia coli and Klebsiella pneumoniae clinical isolates from Gaza Strip, Palestine. GERMS. 10(1). 18–26. 6 indexed citations
5.
Chhabra, Harvinder Singh, et al.. (2020). Comparison of Functional Outcomes Between Lumbar Interbody Fusion Surgery and Discectomy in Massive Lumbar Disc Herniation: A Retrospective Analysis. Global Spine Journal. 11(5). 690–696. 10 indexed citations
6.
Nagarjuna, D., et al.. (2018). Alarming levels of antimicrobial resistance among sepsis patients admitted to ICU in a tertiary care hospital in India - a case control retrospective study. Antimicrobial Resistance and Infection Control. 7(1). 150–150. 11 indexed citations
7.
Nagarjuna, D., Rajni Gaind, Rakesh Singh Dhanda, & Manisha Yadav. (2017). Whole-Genome Shotgun Sequence of Escherichia coli Strain MN067 from India, a Commensal Bacterium with Potent Pathogenic Ability. Genome Announcements. 5(12). 1 indexed citations
9.
Jain, Shruti, D. Nagarjuna, Rajni Gaind, et al.. (2016). Escherichia vulneris : an unusual cause of complicated diarrhoea and sepsis in an infant. A case report and review of literature. New Microbes and New Infections. 13. 83–86. 13 indexed citations
10.
Nagarjuna, D., Rakesh Singh Dhanda, Rajni Gaind, & Manisha Yadav. (2015). tcpC as a prospective new virulence marker in blood Escherichia coli isolates from sepsis patients admitted to the intensive care unit. New Microbes and New Infections. 7. 28–30. 11 indexed citations
11.
Nagarjuna, D., et al.. (2015). Faecal Escherichia coli isolates show potential to cause endogenous infection in patients admitted to the ICU in a tertiary care hospital. New Microbes and New Infections. 7. 57–66. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026